The UK Health Security Agency and Joint Committee for Vaccination and Immunisation (JCVI) are highlighting the benefits the new Respiratory Syncytial Virus (RSV) vaccination programme is expected to bring following its introduction from September.
A recent detailed analysis[1] estimated that the new programme launching in England this autumn could typically prevent 5,000 hospitalisations and 15,000 emergency department attendances for infants.
Read the full article here.
From:UK Health Security Agency
Published13 August 2024